Mavens Biotech net profit declines 52.63% in the March 2013 quarter
Capital MarketNet profit of Mavens Biotech declined 52.63% to Rs 0.09 crore in the quarter ended March 2013 as against Rs 0.19 crore during the previous quarter ended March 2012. Sales rose 2.38% to Rs 11.61 crore in the quarter ended March 2013 as against Rs 11.34 crore during the previous quarter ended March 2012.
For the Audited full year,net profit rose 1.43% to Rs 0.71 crore in the year ended March 2013 as against Rs 0.70 crore during the previous year ended March 2012. Sales rose 0.59% to Rs 45.83 crore in the year ended March 2013 as against Rs 45.56 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales11.6111.34
2 45.8345.56
1 OPM %1.292.29
-44 2.052.33
-12 PBDT0.160.28
-43 1.031.17
-12 PBT0.090.19
-53 0.750.80
-6 NP0.090.19
-53 0.710.70
1 Powered by Capital Market - Live News